Visudyne Medicare Coverage Denial Disputed In Lawsuit
Executive Summary
A lawsuit challenging the denial of Medicare coverage for QLT/Novartis' Visudyne could compel CMS to establish an appeals process for all National Coverage Determinations
You may also be interested in...
Visudyne Medicare Settlement: CMS Cmte To Review Occult Lesion Data
CMS' Medicare Coverage Advisory Committee will review initial data from QLT's Phase III trial of Visudyne (verteporfin) for age-related macular degeneration patients with occult lesions
Visudyne Medicare Settlement: CMS Cmte To Review Occult Lesion Data
CMS' Medicare Coverage Advisory Committee will review initial data from QLT's Phase III trial of Visudyne (verteporfin) for age-related macular degeneration patients with occult lesions
Medicare Coverage Policy Could Stand Despite Successful Appeal – CMS Rule
A successful challenge of a national or local Medicare coverage determination would not necessarily reverse the policy for all beneficiaries, a 1CMS proposed rule says